- HgCapital, the manager of HgCapital Trust plc, has announced a majority investment in Kinapse, a leading global provider of advisory, capability building and operational services to the life sciences industry, headquartered in London. The terms of this transaction were not disclosed. HgCapital Trust plc will invest in Kinapse alongside other institutional clients of HgCapital, who will participate through the HgCapital 7 Fund. The trust will contribute a total of approximately GBP10.0 million. The acquisition of Kinapse represents the eighth investment by the HgCapital 7 Fund, and following completion, the Fund will be approximately 55% invested.

Story provided by